Sacubitril calcium

Sacubitril calcium is the calcium salt form of sacubitril, that is a prodrug and neprilysin inhibitor. It is used in combination with valsartan as a treatment for heart failure. Sacubitril is converted in the body to its active metabolite LBQ657, which inhibits neprilysin, an enzyme that degrades natriuretic peptides like atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), leading to vasodilation, natriuresis, and diuresis, which help lower blood pressure and reduce heart failure symptoms. Sacubitril calcium is orally bioavailable and studied mostly as part of the combination drug sacubitril/valsartan (brand name Entresto). The directory classifies it as a under development API with a synthetic source/manufacturing origin. Other names for this substance include Sacubitril hemicalcium salt and AHU-377 calcium salt. Its PubChem CID is 92045585.

CAS No 1369773-39-6
Molecular Formula C48H56CaN2O10
Molecular Weight 861.0 g/mol
Synonyms calcium;4-[[(2S,4R)-5-ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]amino]-4-oxobutanoate

Frequently Asked Questions